We are live on ! Find out more
Carmignac Gestion

Carmignac Gestion Portfolio holdings

AUM $7.71B Turnover 49.25%
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+18.87%
1 Year Est. Return
+4.02%
3 Year Est. Return
+85.13%
5 Year Est. Return
+112.24%
10 Year Est. Return
+570.29%
AUM
$6.32B
AUM Growth
+$368M
Cap. Flow
-$546M
Cap. Flow %
-8.64%
Top 10 Hldgs %
51.92%
Holding
171
New
23
Increased
43
Reduced
58
Closed
27
Avg Time Held Equity + Options
2.3 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
1.6 years
Avg Time Held Equity only
2.4 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.6 years

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$289M
2
NVDA icon
NVIDIA
NVDA
+$154M
3
HUM icon
Humana
HUM
+$117M
4
BIIB icon
Biogen
BIIB
+$93.5M
5
BEKE icon
KE Holdings
BEKE
+$56.1M

Sector Composition

Rank Sector Weight
1 Technology 32.45%
2 Communication Services 16.22%
3 Consumer Discretionary 11.63%
4 Healthcare 10.27%
5 Financials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MTZ icon
126
MasTec
MTZ
$15.4B
$836K 0.01%
8,960
-20,000
-69% -$1.52M
2021 Q1
12 quarters
NDSN icon
127
Nordson
NDSN
$18.3B
$792K 0.01%
2,886
-1,700
-37% -$443K
2021 Q3
10 quarters
GLOB icon
128
Globant
GLOB
$1.69B
$707K 0.01%
3,500
-235
-6% -$52.8K
2023 Q3
2 quarters
QFIN icon
129
Qfin Holdings
QFIN
$708M
$526K 0.01%
+28,562
New +$448K
2024 Q1
0 quarters
NOV icon
130
NOV
NOV
$6.64B
$488K 0.01%
25,000
– –
2021 Q4
9 quarters
CORT icon
131
Corcept Therapeutics
CORT
$12.3B
$427K 0.01%
16,943
-8,877
-34% -$210K
2022 Q4
5 quarters
SEDG icon
132
SolarEdge
SEDG
$1.93B
$424K 0.01%
5,975
– –
2020 Q3
14 quarters
DAVA icon
133
Endava
DAVA
$109M
$380K 0.01%
10,000
-1,000
-9% -$60.1K
2023 Q3
2 quarters
RUN icon
134
Sunrun
RUN
$1.84B
$351K 0.01%
26,626
– –
2020 Q3
14 quarters
NOVA icon
135
DELISTED
Sunnova Energy
NOVA
$257K ﹤0.01%
41,999
– –
2020 Q4
13 quarters
PLUG icon
136
Plug Power
PLUG
$2.08B
$231K ﹤0.01%
67,284
– –
2022 Q3
6 quarters
BIDU icon
137
Baidu
BIDU
$28.1B
$83.3K ﹤0.01%
791
– –
2021 Q3
10 quarters
NWLI icon
138
DELISTED
National Western Life Group, Inc. Class A
NWLI
$59K ﹤0.01%
+120
New +$58.2K
2024 Q1
0 quarters
GOOG icon
139
CALL
Alphabet (Google) Class C
GOOG
$4.22T
– –
0
– –
2024 Q1
0 quarters
GOOGL icon
140
CALL
Alphabet (Google) Class A
GOOGL
$4.27T
– –
0
– –
2024 Q1
0 quarters
MU icon
141
CALL
Micron Technology
MU
$1.05T
– –
0
– –
2024 Q1
0 quarters
DSKE
142
DELISTED
Daseke, Inc. Common Stock
DSKE
$25.1K ﹤0.01%
+3,020
New +$24.7K
2024 Q1
0 quarters
TSLA icon
143
CALL
Tesla
TSLA
$1.43T
– –
0
– –
2024 Q1
0 quarters
AMED icon
144
DELISTED
Amedisys
AMED
– –
-33,725
Closed -$3.21M –
BANC icon
145
Banc of California
BANC
$2.73B
– –
-160,205
Closed -$2.15M –
BIIB icon
146
Biogen
BIIB
$34.8B
– –
-361,395
Closed -$93.5M –
BMY icon
147
Bristol-Myers Squibb
BMY
$124B
$0 ﹤0.01%
+27,804
New +$1.42M
2024 Q1
0 quarters
DE icon
148
Deere & Co
DE
$175B
– –
-24,926
Closed -$9.97M –
GDDY icon
149
GoDaddy
GDDY
$13.6B
– –
-29,568
Closed -$3.14M –
HUM icon
150
Humana
HUM
$51.9B
– –
-254,777
Closed -$117M –

Similar funds

Carmignac Gestion's Q1 2024 Portfolio in Review

As of Q1 2024, Carmignac Gestion held 171 positions worth $6.32B, up 6.2% from $5.95B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Carmignac Gestion withdrew a net $546M in Q1 2024, closing 27 positions and reducing 58 holdings. Its most notable exit was Humana, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 26% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Carmignac Gestion opened a new position in Micron Technology worth $182M.

  • Carmignac Gestion's largest Q1 2024 buy was Micron Technology: 1,544,544 shares worth $182M.
  • Carmignac Gestion added most to Meta Platforms (Facebook) in Q1 2024, an estimated $52.6M increase.
  • Carmignac Gestion's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $289M.
  • Carmignac Gestion fully exited Humana in Q1 2024, selling an estimated $117M.
  • Carmignac Gestion's ten largest holdings make up 52% of its $6.32B portfolio in Q1 2024.
  • Carmignac Gestion opened 23 new positions and closed 27 in Q1 2024.
  • Carmignac Gestion's portfolio value rose 6.2% quarter-over-quarter to $6.32B.

Based on Carmignac Gestion's 13F filing for Q1 2024, filed 14 May 2024.